Linking cholesterol metabolism in myeloid cells to remyelination in mice and humans

B07

This project addresses a fundamental question in the field of multiple sclerosis, namely why remyelination mostly fails in progressive MS. Myeloid cells are the dominating inflammatory cell population in active and mixed active/inactive MS lesions. Our recent animal experiments demonstrated that accumulation of myelin debris in myeloid cells can induce a maladaptive immune response that impedes remyelinationm. Yet the mechanisms underlying the block of myelin repair are unknown. We want to understand how different functional states of myeloid cells are linked to oligodendrocytes and remyelination in MS lesions. These are our main questions::

    1. How does cholesterol clearance in phagocytes affect oligodendrocytes and remyelination in demyelinating animal models?
    2. Are lipidated particles that are formed after myelin debris clearance reutilized by oligodendrocytes and required for remyelination?
    3. How do supernatants from phagocytes at different stages of cholesterol clearance affect oligodendroglial differentiation, migration, myelination or cell death? What are the underlying molecular mechanisms?
    4. Do supernatants from phagocytes at different stages of cholesterol clearance induce cellular senescence in oligodendrocytes?
    5. Are different stages of cholesterol clearance associated with lesion activity or ongoing or impaired remyelination?

 

 

 

 

 

 

 

 

 

 

 

 

 

Principal Investigators:

Univ.-Prof. Dr. med. Tanja Kuhlmann
Institut für Neuropathologie
Münster
tanja.kuhlmann@ukmuenster.de

Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München
msimons@gwdg.de

News

Mon, 20/09/2021
Register now: 1st Symposium inflammation and imaging
When?: from November 2nd to November 4th 2021 Where?: Schloss (seat of the University Administration) Muenster Organizers: Co-operative Research Centres 1009, 1450, Transregio 128, and Clinical Research Unit 342 – together with Interdisciplinary Centre of Clinical Research (IZKF) and Excellence Cluster Cells in Motion (CiM) Registration is open now! More information: here...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more